Paediatric Haematology Flashcards

1
Q

Haemoglobin

A

Haemoglobin is formed of four protein subunits. These four subunits are made of two pairs of subunits. Fetal haemoglobin (HbF) has two alpha and two gamma subunits. Adult haemoglobin (HbA) has two alpha and two beta subunits.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Differences with Adult Haemoglobin

A

The structure gives fetal haemoglobin a greater affinity to oxygen than adult haemoglobin. Oxygen binds to fetal haemoglobin more easily and is more reluctant to let go. This is important, as fetal haemoglobin needs to “steal” oxygen away from the mother’s haemoglobin when nearby in the placenta. If the fetal and maternal haemoglobin had the same affinity for oxygen, there would be no incentive for the oxygen to switch from the maternal blood to fetal blood.

The affinity of fetal and adult haemoglobin with oxygen can be illustrated with the oxygen dissociation curve. This is an exam favourite. Along the x-axis is the partial pressure of oxygen, which is how much oxygen is crammed into a space. The higher the partial pressure, the more oxygen is in the area. On the y-axis is the percentage of the haemoglobin molecule that is bound to oxygen. This is how “full” the haemoglobin molecule is.

As the partial pressure of oxygen goes up, more oxygen will be bound to haemoglobin. Adult haemoglobin requires a higher partial pressure of oxygen for the molecule to fill with oxygen compared with fetal haemoglobin.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

At birth

A

From 32 to 36 weeks gestation, production of HbF decreases. At the same time HbA is produced in greater quantities. Over time there is a gradual transition from HbF to HbA. At birth, around half the haemoglobin produced is HbF and half is HbA. By 6 months of age, very little fetal haemoglobin is produced. Eventually, red blood cells contain entirely HbA.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Fetal Haemoglobin in Sickle Cell Disease

A

In sickle cell disease, a genetic abnormality coding for the beta subunit is responsible for causing the sickle shape of the red blood cells. Fetal haemoglobin does not lead to sickling of red blood cells because there is no beta subunit in the structure.

Hydroxycarbamide can be used to increase the production of fetal haemoglobin (HbF) in patients with sickle cell anaemia. This has a protective effect against sickle cell crises and acute chest syndrome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Causes of Anaemia In Infancy

A

Physiologic anaemia of infancy causes most cases of anaemia in infancy.

The other causes of anaemia in infants are:

Anaemia of prematurity
Blood loss
Haemolysis
Twin-twin transfusion, where blood is unequally distributed between twins that share a placenta
Haemolysis is a common cause of anaemia in infancy. There are a number of causes of haemolysis in a neonate:

Haemolytic disease of the newborn (ABO or rhesus incompatibility)
Hereditary spherocytosis
G6PD deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Physiologic Anaemia of Infancy

A

There is a normal dip in haemoglobin around six to nine weeks of age in healthy term babies. High oxygen delivery to the tissues caused by the high haemoglobin levels at birth cause negative feedback. Production of erythropoietin by the kidneys is suppressed and subsequently there is reduced production of haemoglobin by the bone marrow. The high oxygen results in lower haemoglobin production.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Anaemia of Prematurity

A

Premature neonates are much more likely to become significantly anaemic during the first few weeks of life compared with term infants. The more premature the infant, the more likely they are to require one or more transfusions for anaemia. This becomes more likely if they are unwell at birth, particularly with neonatal sepsis.

Premature neonates become anaemic for a number of reasons:

Less time in utero receiving iron from the mother
Red blood cell creation cannot keep up with the rapid growth in the first few weeks
Reduced erythropoietin levels
Blood tests remove a significant portion of their circulating volume

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Haemolytic Disease of the Newborn

A

Haemolytic disease of the newborn is a cause haemolysis (red blood cells breaking down) and jaundice in the neonate. It is caused by incompatibility between the rhesus antigens on the surface of the red blood cells of the mother and fetus. The rhesus antigens on the red blood cells vary between individual. This is different to the ABO blood group system.

Within the rhesus group, there are many different types of antigens that can be present or absent depending on the person’s blood type. The most important antigen within the rhesus blood group system is the rhesus D antigen.

When a woman that is rhesus D negative (does not have the rhesus D antigen) becomes pregnant, we have to consider the possibility that the fetus will be rhesus D positive (has the rhesus D antigen). It is likely at some point in the pregnancy the blood from the fetus will find a way into her bloodstream. When this happens, the fetal red blood cells display the rhesus D antigen. The mother’s immune system will recognise the rhesus D antigen as foreign and produce antibodies to the rhesus D antigen. The mother has then become sensitised to rhesus D antigens.

Usually, this sensitisation process does not cause problems during the first pregnancy (unless the sensitisation happens early on, such as during antepartum haemorrhage). During subsequent pregnancies, the mothers anti-D antibodies can cross the placenta into the fetus. If that fetus is rhesus positive, these antibodies attach themselves to the red blood cells of the fetus and causes the immune system of the fetus to attack its own red blood cells. This leads to haemolysis, causing anaemia and high bilirubin levels. This leads to a condition called haemolytic disease of the newborn.

A direct Coombs test (DCT) can be used to check for immune haemolytic anaemia. This will be positive in haemolytic disease of the newborn.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Causes of Anaemia in Older Children

A

The key causes of anaemia in older children are:

Iron deficiency anaemia secondary to dietary insufficiency. This is the most common cause overall.
Blood loss, most frequently from menstruation in older girls
Rarer causes of anaemia in children include:

Sickle cell anaemia
Thalassaemia
Leukaemia
Hereditary spherocytosis
Hereditary eliptocytosis
Sideroblastic anaemia
Worldwide, a common cause of blood loss causing chronic anaemia and iron deficiency is helminth infection, with roundworms, hookworms or whipworms. This can be very common in developing countries and those living in poverty. It is more unusual in the UK. Treatment is with a single dose of albendazole or mebendazole.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Categorising Anaemia

A

Anaemia is initially subdivided into three main categories based on the size of the red blood cell (the MCV). These have different underlying causes:

Microcytic anaemia (low MCV indicating small RBCs)
Normocytic anaemia (normal MCV indicating normal sized RBCs)
Macrocytic anaemia (large MCV indicating large RBCs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Causes of Microcytic Anaemia

A

A helpful mnemonic for understanding the causes of microcytic anaemia is TAILS.

T – Thalassaemia
A – Anaemia of chronic disease
I – Iron deficiency anaemia
L – Lead poisoning
S – Sideroblastic anaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Causes of Normocytic Anaemia

A

There are 3 As and 2 Hs for normocytic anaemia:

A – Acute blood loss
A – Anaemia of Chronic Disease
A – Aplastic Anaemia
H – Haemolytic Anaemia
H – Hypothyroidism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Causes of Macrocytic Anaemia

A

Macrocytic anaemia can be megaloblastic or normoblastic. Megaloblastic anaemia is the result of impaired DNA synthesis preventing the cell from dividing normally. Rather than dividing it keeps growing into a large, abnormal cell. This is caused by a vitamin deficiency.

Megaloblastic anaemia is caused by:

B12 deficiency
Folate deficiency
Normoblastic macrocytic anaemia is caused by:

Alcohol
Reticulocytosis (usually from haemolytic anaemia or blood loss)
Hypothyroidism
Liver disease
Drugs such as azathioprine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Symptoms of anaemia

A

There are many generic symptoms of anaemia:

Tiredness
Shortness of breath
Headaches
Dizziness
Palpitations
Worsening of other conditions
There are symptoms specific to iron deficiency anaemia:

Pica describes dietary cravings for abnormal things such as dirt and can signify iron deficiency
Hair loss can indicate iron deficiency anaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Signs of anaemia

A

Generic signs of anaemia:

Pale skin
Conjunctival pallor
Tachycardia
Raised respiratory rate
Signs of specific causes of anaemia:

Koilonychia refers to spoon shaped nails, which can indicate iron deficiency
Angular chelitis can indicate iron deficiency
Atrophic glossitis is a smooth tongue due to atrophy of the papillae and can indicate iron deficiency
Brittle hair and nails can indicate iron deficiency
Jaundice occurs in haemolytic anaemia
Bone deformities occur in thalassaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Investigating anaemia

A

Initial Investigations:

Full blood count for haemoglobin and MCV
Blood film
Reticulocyte count
Ferritin (low iron deficiency)
B12 and folate
Bilirubin (raised in haemolysis)
Direct Coombs test (autoimmune haemolytic anaemia)
Haemoglobin electrophoresis (haemoglobinopathies)
Reticulocytes are immature red blood cells. A high level of reticulocytes in the blood indicates active production of red blood cells to replace lost cells. This usually indicates the anaemia is due to haemolysis or blood loss.

Further investigation will depend on the suspected underlying cause.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Managing anaemia

A

Management depends on establishing the underlying cause and directing treatment accordingly. Iron deficiency can be treated with iron supplementation. Severe anaemia may require blood transfusions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Iron deficiency anaemia

A

The bone marrow requires iron to produce haemoglobin. There are several scenarios where iron stores can be used up and the patient becomes iron deficient:

Dietary insufficiency. This is the most common cause in children.
Loss of iron, for example in heavy menstruation
Inadequate iron absorption, for example in Crohn’s disease

Iron is mainly absorbed in the duodenum and jejunum. It requires the acid from the stomach to keep the iron in the soluble ferrous (Fe2+) form. When there is less acid in the stomach, it changes to the insoluble ferric (Fe3+) form. Therefore, medications that reduce the stomach acid, such as proton pump inhibitors (lansoprazole and omeprazole) can interfere with iron absorption. Conditions that result in inflammation of the duodenum or jejunum such as coeliac disease or Crohn’s disease can also cause inadequate iron absorption.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Tests for iron deficiency

A

Iron travels around the blood as ferric ions (Fe3+) bound to a carrier protein called transferrin. Total iron binding capacity (TIBC) basically means the total space on the transferrin molecules for the iron to bind. Therefore, total iron binding capacity is directly related to the amount of transferrin in the blood. If you measure iron in the blood and then measure the total iron binding capacity of that blood, you can calculate the proportion of the transferrin molecules that are bound to iron. This is called the transferrin saturation. It is expressed as a percentage. The formula is:

Transferrin Saturation = Serum Iron / Total Iron Binding Capacity

Ferritin is the form that iron takes when it is deposited and stored in cells. Extra ferritin is released from cells when there is inflammation, such as with infection or cancer. If ferritin in the blood is low, this is highly suggestive of iron deficiency. High ferritin is difficult to interpret and is likely to be related to inflammation rather than iron overload. A patient with a normal ferritin can still have iron deficiency anaemia, particularly if they have reasons to have a raised ferritin, such as infection.

Serum iron varies significantly throughout the day, with higher levels in the morning and after eating iron containing meals. On its own serum iron is not a very useful measure.

Total iron binding capacity can be used as a marker for how much transferrin is in the blood. It is an easier test to perform than measuring transferrin. Both TIBC and transferrin levels increase in iron deficiency and decrease in iron overload.

Transferrin saturation gives a good indication of the total iron in the body. In normal adults it is around 30%, however if there is less iron in the body, transferrin will be less saturated. When iron levels go up, transferrin will be more saturated. It can increase shortly after eating a meal rich in iron or taking iron supplements, so a fasting sample is better.

Blood Test
Normal Range
Serum Ferritin
12 – 200 ug/L
Serum Iron
14 – 31 μmol/L
Total Iron Binding Capacity
54 – 75 μmol/L
Two things can increase the values of all of these results (except TIBC, which will be low), giving the impression of iron overload:

Supplementation with iron
Acute liver damage (lots of iron is stored in the liver)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Managing iron deficiency

A

Management involves treating the underlying cause and correcting the anaemia. In children the underlying cause is usually dietary deficiency, so input from a dietician can be helpful.

Iron can be supplemented with ferrous sulphate or ferrous fumarate. This slowly corrects the iron deficiency. Oral iron causes constipation and black coloured stools. It is unsuitable where malabsorption is the cause of the anaemia.

Blood transfusions are very rarely necessary. Children are generally able to tolerate a low haemoglobin well and can be given time to correct their anaemia.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Leukaemia

A

Leukaemia is the name for cancer of a particular line of the stem cells in the bone marrow. This causes unregulated production of certain types of blood cells. Types of leukaemia can be classified depending on how rapidly they progress (chronic is slow and acute is fast) and the cell line that is affected (myeloid or lymphoid).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Types of Leukaemia

A

The types of leukaemia that affect children from most to least common are:

Acute lymphoblastic leukaemia (ALL) is the most common in children
Acute myeloid leukaemia (AML) is the next most common
Chronic myeloid leukaemia (CML) is rare
Rarer and very specialist leukemias exist, but you are very unlikely to encounter them.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Ages of leukaemias

A

ALL peaks aged 2 – 3 years
AML peaks aged under 2 years

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Pathophysiology of leukaemia

A

Leukaemia is a form of cancer of the cells in the bone marrow. A genetic mutation in one of the precursor cells in the bone marrow leads to excessive production of a single type of abnormal white blood cell.

The excessive production of a single type of cell can lead to suppression of the other cell lines, causing underproduction of other cell types. This results in a pancytopenia, which is a combination of low:

Red blood cells (anaemia),
White blood cells (leukopenia)
Platelets (thrombocytopenia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Risk factors for leukaemia

A

Radiation exposure, for example with an abdominal xray during pregnancy, is the main environmental risk factor for leukaemia.

There are several conditions that predispose to a higher risk of developing leukaemia:

Down’s syndrome
Kleinfelter syndrome
Noonan syndrome
Fanconi’s anaemia

26
Q

Presentation of leukaemia

A

The presentation of leukaemia is typically non-specific. Symptoms can include:

Persistent fatigue
Unexplained fever
Failure to thrive
Weight loss
Night sweats
Pallor (anaemia)
Petechiae and abnormal bruising (thrombocytopenia)
Unexplained bleeding (thrombocytopenia)
Abdominal pain
Generalised lymphadenopathy
Unexplained or persistent bone or joint pain
Hepatosplenomegaly

27
Q

Diagnosing leukaemia

A

NICE recommend referring any child with unexplained petechiae or hepatomegaly for immediate specialist assessment.

If leukaemia is suspected based on the non-specific signs above, NICE recommend a very urgent full blood count within 48 hours.

Investigations to establish the diagnosis:

Full blood count, which can show anaemia, leukopenia, thrombocytopenia and high numbers of the abnormal WBCs
Blood film, which can show blast cells
Bone marrow biopsy
Lymph node biopsy

Further tests may be required for staging:

Chest xray
CT scan
Lumbar puncture
Genetic analysis and immunophenotyping of the abnormal cells

28
Q

Managing leukaemia

A

Treatment of leukaemia will be coordinated by a paediatric oncology multi-disciplinary team. Leukaemia is primarily treated with chemotherapy.

Other therapies:

Radiotherapy
Bone marrow transplant
Surgery

29
Q

Complications of Chemotherapy

A

Failure to treat the leukaemia
Stunted growth and development
Immunodeficiency and infections
Neurotoxicity
Infertility
Secondary malignancy
Cardiotoxicity

30
Q

Prognosis of leukaemia

A

The overall cure rate for ALL is around 80%, but prognosis depends on individual factors. The outcomes are less positive for AML.

31
Q

Idiopathic thrombocytopenic purpura

A

Idiopathic thrombocytopenic purpura (ITP) is a condition characterised by idiopathic (spontaneous) thrombocytopenia (low platelet count) causing a purpuric rash (non-blanching rash).

ITP is caused by a type II hypersensitivity reaction. It is caused by the production of antibodies that target and destroy platelets. This can happen spontaneously, or it can be triggered by something, such as a viral infection.

TOM TIP: ITP is worth remembering as it is a key differential diagnosis of a non-blanching rash.

32
Q

Presentation of ITP

A

Idiopathic thrombocytopenic purpura usually present in children under 10 years old. Often there is a history of a recent viral illness. The onset of symptoms occurs over 24 – 48 hours:

Bleeding, for example from the gums, epistaxis or menorrhagia
Bruising
Petechial or purpuric rash, caused by bleeding under the skin
TOM TIP: Petechiae are pin-prick spots (around 1mm) of bleeding under the skin. Purpura are larger (3 – 10mm) spots of bleeding under the skin. When a large area of blood is collected (more than 10 mm), this is called ecchymoses. These are all non-blanching lesions.

33
Q

Managing ITP

A

The condition can be confirmed by doing an urgent full blood count for the platelet count. Other values on the FBC should be normal. Other causes of a low platelet count should be excluded, for example heparin induced thrombocytopenia and leukaemia.

The severity and management depends on how low the platelet count falls. Usually no treatment is required and patients are monitored until the platelets return to normal. Around 70% of patients will remit spontaneously within 3 months.

Treatment may be required if the patient is actively bleeding or severe thrombocytopenia (platelets below 10):

Prednisolone
IV immunoglobulins
Blood transfusions if required
Platelet transfusions only work temporarily
Platelet transfusions only work temporarily because the antibodies against platelets will begin destroying the transfused platelets as soon as they are infused.

Some key education and advice is necessary:

Avoid contact sports
Avoid intramuscular injections and procedures such as lumbar punctures
Avoid NSAIDs, aspirin and blood thinning medications
Advice on managing nosebleeds
Seek help after any injury that may cause internal bleeding, for example car accidents or head injuries

34
Q

Complications of ITP

A

Chronic ITP
Anaemia
Intracranial and subarachnoid haemorrhage
Gastrointestinal bleeding

35
Q

Pathophysiology of sickle cell anaemia

A

Sickle cell anaemia is a genetic condition that causes sickle (crescent) shaped red blood cells.

The abnormal shape makes the red blood cells more fragile and easily destroyed, leading to haemolytic anaemia. Patients with sickle cell anaemia are prone to various sickle cell crises.

Pathophysiology

Haemoglobin is the protein in red blood cells that transports oxygen. During fetal development, at around 32-36 weeks gestation, fetal haemoglobin (HbF) production decreases, and adult haemoglobin (HbA) increases. There is a gradual transition from HbF to HbA. At birth, around half the haemoglobin is HbF, and half is HbA. By six months of age, very little HbF is produced, and red blood cells contain almost entirely HbA.

Patients with sickle-cell disease have an abnormal variant called haemoglobin S (HbS). HbS results in sickle-shaped red blood cells.

Sickle cell anaemia is an autosomal recessive condition affecting the gene for beta-globin on chromosome 11. One abnormal copy of the gene results in sickle-cell trait. Patients with sickle-cell trait are usually asymptomatic. They are carriers of the condition. Two abnormal copies result in sickle-cell disease.

36
Q

Sickle cell anaemia relation to malaria

A

Sickle cell disease is more common in patients from areas traditionally affected by malaria, such as Africa, India, the Middle East and the Caribbean. Having one copy of the gene (sickle cell trait) reduces the severity of malaria. As a result, patients with sickle cell trait are more likely to survive malaria and pass on their genes. Therefore, there is a selective advantage to having the sickle cell gene in areas of malaria, making it more common.

37
Q

Screening for sickle cell anaemia

A

Sickle cell disease is tested for on the newborn blood spot screening test at around five days of age.

Pregnant women at high risk of being carriers of the sickle cell gene are offered testing.

38
Q

Complications of sickle cell anaemia

A

Anaemia
Increased risk of infection
Chronic kidney disease
Sickle cell crises
Acute chest syndrome
Stroke
Avascular necrosis in large joints such as the hip
Pulmonary hypertension
Gallstones
Priapism (painful and persistent penile erections)

39
Q

Sickle Cell Crisis

A

Sickle cell crisis refers to a spectrum of acute exacerbations caused by sickle cell disease. These range from mild to life-threatening. They can occur spontaneously or triggered by dehydration, infection, stress or cold weather.

There is no specific treatment for sickle cell crisis. They are managed supportively, with:

Low threshold for admission to hospital
Treating infections that may have triggered the crisis
Keep warm
Good hydration (IV fluids may be required)
Analgesia (NSAIDs should be avoided where there is renal impairment)

40
Q

Vaso-occlusive Crisis in sickle cell anaemia

A

Vaso-occlusive crisis (VOC) is also known as painful crisis and is the most common type of sickle cell crisis. It is caused by the sickle-shaped red blood cells clogging capillaries, causing distal ischaemia.

It typically presents with pain and swelling in the hands or feet but can affect the chest, back, or other body areas. It can be associated with fever.

It can cause priapism in men by trapping blood in the penis, causing a painful and persistent erection. Priapism is a urological emergency, treated by aspirating blood from the penis.

41
Q

Splenic Sequestration Crisis in sickle cell anaemia

A

Splenic sequestration crisis is caused by red blood cells blocking blood flow within the spleen. It causes an acutely enlarged and painful spleen. Blood pooling in the spleen can lead to severe anaemia and hypovolaemic shock.

Splenic sequestration crisis is considered an emergency. Management is supportive, with blood transfusions and fluid resuscitation to treat anaemia and shock.

Splenic sequestration crisis can lead to splenic infarction, leading to hyposplenism and susceptibility to infections, particularly by encapsulated bacteria (e.g., Streptococcus pneumoniae and Haemophilus influenzae).

Splenectomy prevents sequestration crises and may be used in recurrent cases.

42
Q

Aplastic crisis in sickle cell anaemia

A

Aplastic crisis describes a temporary absence of the creation of new red blood cells. It is usually triggered by infection with parvovirus B19.

It leads to significant anaemia (aplastic anaemia). Management is supportive, with blood transfusions if necessary. It usually resolves spontaneously within around a week.

43
Q

Acute chest syndrome

A

chest syndrome occurs when the vessels supplying the lungs become clogged with red blood cells. A vaso-occlusive crisis, fat embolism or infection can trigger it.

Acute chest syndrome presents with fever, shortness of breath, chest pain, cough and hypoxia. A chest x-ray will show pulmonary infiltrates.

Acute chest syndrome is a medical emergency with high mortality. It requires prompt supportive management and treatment of the underlying cause:

Analgesia
Good hydration (IV fluids may be required)
Antibiotics or antivirals for infection
Blood transfusions for anaemia
Incentive spirometry using a machine that encourages effective and deep breathing
Respiratory support with oxygen, non-invasive ventilation or mechanical ventilation

44
Q

Management of sickle cell anaemia

A

specialist MDT will manage sickle cell disease. The general principles are:

Avoid triggers for crises, such as dehydration
Up-to-date vaccinations
Antibiotic prophylaxis to protect against infection, typically with penicillin V (phenoxymethylpenicillin)
Hydroxycarbamide (stimulates HbF)
Crizanlizumab
Blood transfusions for severe anaemia
Bone marrow transplant can be curative

Hydroxycarbamide works by stimulating the production of fetal haemoglobin (HbF). Fetal haemoglobin does not lead to the sickling of red blood cells (unlike HbS). It reduces the frequency of vaso-occlusive crises, improves anaemia and may extend lifespan.

Crizanlizumab is a monoclonal antibody that targets P-selectin. P-selectin is an adhesion molecule found on endothelial cells on the inside walls of blood vessels and platelets. It prevents red blood cells from sticking to the blood vessel wall and reduces the frequency of vaso-occlusive crises.

45
Q

Hereditary spherocytosis

A

Hereditary spherocytosis is a condition where the red blood cells are sphere shaped, making them fragile and easily destroyed when passing through the spleen. It is the most common inherited haemolytic anaemia in northern Europeans. It is an autosomal dominant condition.

46
Q

Presentation of hereditary spherocytosis

A

Hereditary spherocytosis presents with:

Jaundice
Anaemia
Gallstones
Splenomegaly
Patients can have episodes of haemolytic crisis, often triggered by infections, where the haemolysis, anaemia and jaundice is more significant.

Patients with hereditary spherocytosis can develop aplastic crisis. During aplastic crisis there is increased anaemia, haemolysis and jaundice, without the normal response from the bone marrow of creating new red blood cells. Usually the bone marrow will respond to haemolysis by producing red blood cells faster, demonstrated by extra reticulocytes (immature red blood cells) in the blood. In aplastic crisis there is no reticulocyte response. This is often triggered by infection with parvovirus.

TOM TIP: Infection with parvovirus causing aplastic crisis is a classic exam features of hereditary spherocytosis. It is worth remembering this connection, as there are multiple ways examiners like to ask this. A patient with spherocytosis may present with anaemia and you could be asked to identify the causative infectious agent. Alternatively, someone affected by parvovirus could develop anaemia and jaundice and you may be asked the underlying diagnosis.

47
Q

Diagnosing hereditary spherocytosis

A

Hereditary spherocytosis is diagnosed by family history and clinical features, along with spherocytes on the blood film. The mean corpuscular haemoglobin concentration (MCHC) is raised on a full blood count. Reticulocytes will be raised due to rapid turnover of red blood cells.

48
Q

Managing hereditary spherocytosis

A

Treatment is with folate supplementation and splenectomy. Removal of the gallbladder (cholecystectomy) may be required if gallstones are a problem. Transfusions may be required during acute crises.

49
Q

Hereditary Elliptocytosis

A

Hereditary elliptocytosis is very similar to hereditary spherocytosis except that the red blood cells are ellipse shaped. It is also autosomal dominant. Presentation and management are very similar.

50
Q

Thalassaemia

A

Thalassaemia is related to a genetic defect in the protein chains that make up haemoglobin. Normal haemoglobin consists of 2 alpha and 2 beta globin chains. Defects in the alpha globin chains lead to alpha thalassaemia. Defects in the beta globin chains lead to beta thalassaemia. Both conditions are autosomal recessive. The overall effect is varying degrees of anaemia, depending on the type and mutation.

In patients with thalassaemia the red blood cells are more fragile and break down more easily. The spleen acts as a sieve to filter the blood and remove older blood cells. In patients with thalassaemia, the spleen collects all the destroyed red blood cells, resulting in splenomegaly.

The bone marrow expands to produce extra red blood cells to compensate for the chronic anaemia. This causes a susceptibility to fractures and prominent features, such as a pronounced forehead and malar eminences (cheek bones).

51
Q

Signs and symptoms of thalassaemia

A

Microcytic anaemia (low mean corpuscular volume)
Fatigue
Pallor
Jaundice
Gallstones
Splenomegaly
Poor growth and development
Pronounced forehead and malar eminences

52
Q

Diagnosing thalassaemia

A

Full blood count shows a microcytic anaemia.
Haemoglobin electrophoresis is used to diagnose globin abnormalities.
DNA testing can be used to look for the genetic abnormality
Pregnant women in the UK are offered a screening test for thalassaemia at booking.

53
Q

Iron overload in thalassaemia

A

Iron overload occurs in thalassaemia as a result of the faulty creation of red blood cells, recurrent transfusions and increased absorption of iron in the gut in response to anaemia.

Patients with thalassaemia have serum ferritin levels monitored to check for iron overload. Management of iron overload involves limiting transfusions and performing iron chelation.

Iron overload in thalassaemia causes effects similar to haemochromatosis:

Fatigue
Liver cirrhosis
Infertility
Impotence
Heart failure
Arthritis
Diabetes
Osteoporosis and joint pain

54
Q

Alpha-Thalassaemia

A

Alpha-thalassaemia is caused by defects in alpha globin chains. The gene coding for this protein is on chromosome 16.

Management:

Monitoring the full blood count
Monitoring for complications
Blood transfusions
Splenectomy may be performed
Bone marrow transplant can be curative

55
Q

Beta-Thalassaemia

A

Beta-thalassaemia is caused by defects in beta globin chains. The gene coding for this protein is on chromosome 11.

The gene defect can either consist of abnormal copies that retain some function or deletion genes where there is no function in the beta globin protein at all. Based on the type of defect, beta-thalassamia can be split into three types:

Thalassaemia minor
Thalassaemia intermedia
Thalassaemia major

56
Q

Thalassaemia Minor

A

Patients with beta thalassaemia minor are carriers of an abnormally functioning beta globin gene. They have one abnormal and one normal gene.

Thalassaemia minor causes a mild microcytic anaemia and usually patients only require monitoring and no active treatment.

57
Q

Thalassaemia Intermedia

A

Patients with beta thalassaemia intermedia have two abnormal copies of the beta globin gene. This can be either two defective genes or one defective gene and one deletion gene.

Thalassaemia intermedia causes a more significant microcytic anaemia. Patients require monitoring and occasional blood transfusions. When they require more transfusions, they may require iron chelation to prevent iron overload.

58
Q

Thalassaemia Major

A

Patients with beta thalassaemia major are homozygous for the deletion genes. They have no functioning beta globin genes at all. This is the most severe form and usually presents with severe anaemia and failure to thrive in early childhood.

Thalassaemia major causes:

Severe microcytic anaemia
Splenomegaly
Bone deformities
Management involves regular transfusions, iron chelation and splenectomy. Bone marrow transplant can potentially be curative.

59
Q

G6PD deficiency

A

G6PD deficiency is a condition where there is a defect in the G6PD enzyme normally found in all cells in the body.

It is more common in Mediterranean, Middle Eastern and African patients. It is inherited in an X linked recessive pattern, meaning it usually affects males, as they have only a single copy of the gene on their single X chromosome. It causes crises that are triggered by infections, medications or fava beans (broad beans).

TOM TIP: The key piece of knowledge for G6PD deficiency relates to triggers. In your exam look out for a patient that becomes jaundice and anaemic after eating broad beans, developing an infection or being treated with antimalarial medications. The underlying diagnosis might be G6PD deficiency.

Pathophysiology

The G6PD enzyme is responsible for helping protect cells from damage by reactive oxygen species (ROS). ROS are reactive molecules that contain oxygen, produced during normal cell metabolism and in higher quantities during stress on the cell. The G6PD enzyme is particularly important in red blood cells. A deficiency in G6PD makes cells more vulnerable to ROS, leading to haemolysis in red blood cells. Periods of increased stress, with a higher production of ROS, can lead to acute haemolytic anaemia.

60
Q

Presentation of G6PD deficiency

A

G6PD often presents with neonatal jaundice.

Other features of the condition are:

Anaemia
Intermittent jaundice, particularly in response to triggers
Gallstones
Splenomegaly
Heinz bodies may be seen on a on blood film. Heinz bodies are blobs of denatured haemoglobin (“inclusions”) seen within the red blood cells.

Diagnosis can be made by doing a G6PD enzyme assay.

61
Q

Managing G6PD deficiency

A

Patient should avoid triggers to acute haemolysis where possible. This includes avoiding fava beans and certain medications.

Medications that trigger haemolysis and should be avoided include:

Primaquine (an antimalarial)
Ciprofloxacin
Nitrofurantoin
Trimethoprim
Sulfonylureas (e.g gliclazide)
Sulfasalazine and other sulphonamide drugs